ConductScience.org, home

Gene · 9476

Papers2,888

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Basal ganglia glioblastoma with lung adenocarcinoma tumor-to-tumor metastasis and atypical early imaging presentation: illustrative case.J Neurosurg Case Lessons202641941839PubTator, text miningPubMed
[Clinical Application of the International System for Serous Fluid Cytopathology in the Stratified Diagnosis of Lung Cancer-associated Serous Effusions].Zhongguo Fei Ai Za Zhi202641916912PubTator, text miningPubMed
NUT carcinoma of the upper respiratory tract: Two case reports and literature review.Sci Prog202641906430PubTator, text miningPubMed
Discriminating nodular pulmonary alveolar proteinosis from lung adenocarcinoma with radiomic model and multimodal model.Ther Adv Respir Dis202641905780PubTator, text miningPubMed
Proteomic characterization of intrahepatic cholangiocarcinoma identifies risk-stratifying subgroups and EIF4A1 as a therapeutic target.Nat Commun202641872184PubTator, text miningPubMed
Pituitary Metastasis as the Initial Manifestation of an Undiagnosed Adenocarcinoma of Mullerian Origin: A Case Report and Literature Review.Int J Surg Pathol202641869702PubTator, text miningPubMed
Diagnostic Value of Next-Generation Sequencing (NGS) and Microarray in Characterizing Tumor Origin: A Challenging and Educational Case.Am J Case Rep202641866784PubTator, text miningPubMed
Mechanism of action and clinical application of autophagy in multiple sclerosis (Review).Int J Mol Med202641860040PubTator, text miningPubMed
Immunocytochemical Detection of Napsin-A in Pulmonary Alveolar Proteinosis: A Report of Two Cases.Acta Cytol202641818400PubTator, text miningPubMed
Case Report: Primary clear cell adenocarcinoma of the urethra-imaging features and literature review.Front Oncol202641815541PubTator, text miningPubMed
Clinical and Pathological Characteristics of Stage IV SMARCA4-Deficient Lung Cancer and the Efficacy of Immune Checkpoint Inhibitors.Clin Oncol (R Coll Radiol)202641812299PubTator, text miningPubMed
First-Line Treatment of Advanced Thoracic SMARCA4-Deficient Undifferentiated Tumor: A Case Report and Review of the Literature.Case Rep Oncol Med202641809723PubTator, text miningPubMed
Convex-probe endobronchial ultrasound-guided cryobiopsy for pleural tumors: three case reports.Transl Lung Cancer Res202641808711PubTator, text miningPubMed
A Rare Case of Mediastinal NUT (Nuclear Protein in Testis) Carcinoma Presenting with Acute Respiratory Failure: A Case Report.Int Med Case Rep J202641800272PubTator, text miningPubMed
Metachronous triple primary malignancies: a case report of NGS-guided multidisciplinary management and literature review.Front Oncol202641800046PubTator, text miningPubMed
Endovascular Thrombectomy in a Patient with Acute Ischemic Stroke due to Tumor Emboli Associated with Cardiac Metastasis of Extraskeletal Myxoid Chondrosarcoma: A Case Report.NMC Case Rep J202641799218PubTator, text miningPubMed
ROS-1 Positive Pleural Adenocarcinoma Diagnosed by Semirigid Thoracoscope Using Cryo-Probe in a Middle-Aged Lady: A Case Report.Cureus202641798534PubTator, text miningPubMed
Case Report: Co-Occurrence of Lung Adenocarcinoma and Congenital Dysfibrinogenemia-Diagnostic and Perioperative Management Challenges.Cancer Rep (Hoboken)202641792928PubTator, text miningPubMed
Germ-line exon 21 EGFR V831H mutation in advanced NSCLC resistance to almonertinib: a case report.Front Oncol202641788992PubTator, text miningPubMed
Decoding organ fibrosis: mechanistic insights and emerging therapeutic strategies.Signal Transduct Target Ther202641786685PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/9476/papers?page=3